European urologyPub Date : 2025-03-10DOI: 10.1016/j.eururo.2025.02.012
Rocco Simone Flammia, Costatino Leonardo, Giuseppe Simone
{"title":"Re: Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1)","authors":"Rocco Simone Flammia, Costatino Leonardo, Giuseppe Simone","doi":"10.1016/j.eururo.2025.02.012","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.02.012","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"19 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143582594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
European urologyPub Date : 2025-03-07DOI: 10.1016/j.eururo.2025.02.014
Moises Abraham Adel Domínguez, Andrés Mora Topete, Walter D. Cardona Maya
{"title":"Re: High Sperm Deoxyribonucleic Acid Fragmentation Index Is Associated with an Increased Risk of Preeclampsia Following Assisted Reproduction Treatment","authors":"Moises Abraham Adel Domínguez, Andrés Mora Topete, Walter D. Cardona Maya","doi":"10.1016/j.eururo.2025.02.014","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.02.014","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"17 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143569423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
European urologyPub Date : 2025-03-06DOI: 10.1016/j.eururo.2025.02.024
Tarek Taha , Kira-Lee Koster , Johann S. de Bono
{"title":"T-Cell Engagers in Prostate Cancer: Promise, Challenges, and the Road Ahead","authors":"Tarek Taha , Kira-Lee Koster , Johann S. de Bono","doi":"10.1016/j.eururo.2025.02.024","DOIUrl":"10.1016/j.eururo.2025.02.024","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"87 5","pages":"Pages 559-560"},"PeriodicalIF":25.3,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143560935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Reply to Mario Terlizzi, Youssef Ghannam, and Pierre Blanchard’s Letter to the Editor re: Guillaume Ploussard, Patrick Coloby, Thierry Chevallier, et al. Whole-gland or Subtotal High-intensity Focused Ultrasound Versus Radical Prostatectomy: The Prospective, Noninferiority, Nonrandomized HIFI Trial. Eur Urol. 2025;87:526–533","authors":"Pascal Rischmann , Bob-Valéry Occéan , Guillaume Ploussard","doi":"10.1016/j.eururo.2025.02.018","DOIUrl":"10.1016/j.eururo.2025.02.018","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"87 5","pages":"Page e92"},"PeriodicalIF":25.3,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143569424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
European urologyPub Date : 2025-03-05DOI: 10.1016/j.eururo.2025.02.016
Emilien Seizilles de Mazancourt, Paul Meria
{"title":"Re: A New Technique for the Treatment of Ureteric Stricture After Kidney Transplantation","authors":"Emilien Seizilles de Mazancourt, Paul Meria","doi":"10.1016/j.eururo.2025.02.016","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.02.016","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"11 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143560794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
European urologyPub Date : 2025-03-05DOI: 10.1016/j.eururo.2025.01.028
Niek F. Casteleijn, Robert A. Pol, Benjamin H.J. Doornweerd
{"title":"Re: Angelo Territo, Luca Afferi, Mireia Musquera, et al. Robot-assisted Kidney Transplantation: The 8-year European Experience. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.12.005","authors":"Niek F. Casteleijn, Robert A. Pol, Benjamin H.J. Doornweerd","doi":"10.1016/j.eururo.2025.01.028","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.01.028","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"212 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143560795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
European urologyPub Date : 2025-02-27DOI: 10.1016/j.eururo.2025.02.006
Stephen J. Freedland , John P. Mulhall , Martin Gleave , Ugo De Giorgi , Fred Saad , Antti Rannikko , Jasmina I. Ivanova , Anchen F. Nasr , Arlene L. Reisman , Arijit Ganguli , Pavol Kral , James Turnbull , Neal Shore
{"title":"Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study","authors":"Stephen J. Freedland , John P. Mulhall , Martin Gleave , Ugo De Giorgi , Fred Saad , Antti Rannikko , Jasmina I. Ivanova , Anchen F. Nasr , Arlene L. Reisman , Arijit Ganguli , Pavol Kral , James Turnbull , Neal Shore","doi":"10.1016/j.eururo.2025.02.006","DOIUrl":"10.1016/j.eururo.2025.02.006","url":null,"abstract":"<div><div>EMBARK demonstrated prolonged metastasis-free survival with enzalutamide ± leuprolide versus leuprolide alone for patients with high-risk biochemical recurrence of prostate cancer, with health-related quality of life (HRQoL) maintained. To evaluate treatment effects on sexual activity (SA), item-level analyses of SA-related HRQoL were performed. HRQoL was assessed (baseline, every 12 wk) until metastasis or death. Time to confirmed clinically meaningful deterioration (TTCD; confirmed at next visit) and longitudinal changes in HRQoL were examined using Cox regression and mixed-model repeated measures analyses, respectively. In comparison to leuprolide alone, enzalutamide monotherapy delayed TTCD in interest in sex (8.5 vs 5.6 mo; hazard ratio [HR] 0.70, 95% confidence interval [CI] 0.57–0.87; <em>p</em> < 0.001), extent of SA (5.7 vs 3.0 mo; HR 0.69, 95% CI 0.54–0.90; <em>p</em> = 0.004), satisfaction with sex life (11.1 vs 5.4 mo; HR 0.61, 95% CI 0.45–0.84; <em>p</em> = 0.001), and erectile function (5.5 vs 2.9 mo; HR 0.67, 95% CI 0.50–0.88; <em>p</em> = 0.003). TTCD in SA-related HRQoL was similar with enzalutamide + leuprolide and leuprolide alone, except TTCD in erectile function was shorter by a statistically significant median of 0.1 mo (3 d), which is not clinically meaningful. Longitudinally, no clinically meaningful changes for any SA-related item were observed from baseline to week 205 in any group. SA-related HRQoL preservation seems to be better with enzalutamide monotherapy than with leuprolide alone.</div></div>","PeriodicalId":12223,"journal":{"name":"European urology","volume":"87 5","pages":"Pages 507-511"},"PeriodicalIF":25.3,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143518010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}